"10.1371_journal.pone.0029720","plos one","2012-01-11T00:00:00Z","Burcin Ekser; Edwin Klein; Jing He; Donna B Stolz; Gabriel J Echeverri; Cassandra Long; Chih Che Lin; Mohamed Ezzelarab; Hidetaka Hara; Massimiliano Veroux; David Ayares; David K C Cooper; Bruno Gridelli","Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America; Department of Surgery, Transplantation and Advanced Technologies, Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, Catania, Italy; Division of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Division of Immunogenetics, Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Department of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Revivicor Inc., Blacksburg, Virginia, United States of America; Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT), Palermo, Italy","Performed in vitro assays and in vivo procedures: CL CCL GJE ME HH BE. Performed animal care and follow-up: BE. Supervised the production of genetically-engineered pigs: DA. Co-designed the study and experiments: DKCC BG. Assisted with surgeries: CL CCL GJE ME HH. Participated in the surgical procedures: DKCC. Performed the surgical procedures: BG BE. Performed light microscopy and interpretation: EK. Performed immunohistological studies: JH. Performed electron microscopy: DBS. Participated in preparation and discussion of the manuscript: MV. Co-wrote the manuscript: DKCC BG BE. All authors advised on the writing of the manuscript.","David Ayares owns stock in Revivicor, Inc. The other authors declare no conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","01","Burcin Ekser","BE",13,TRUE,NA,6,NA,3,TRUE,FALSE,FALSE,0,NA,FALSE
